Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-12-22 Taylor Stacy L SVP and General Counsel Sale −15,338 $30.00 $460K 15,036
2021-12-22 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −10,130 5,313
2021-12-22 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −5,208 17,709
2021-12-22 Cohen Chad M Chief Financial Officer Option exercise +10,000 $7.27 $73K 31,604
2021-12-22 Cohen Chad M Chief Financial Officer Sale −10,000 $30.00 $300K 21,604
2021-12-22 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,000 80,000
2021-11-18 ROBINS HARLAN S Chief Scientific Officer Option exercise +300 $6.55 $2K 69,660
2021-11-18 ROBINS HARLAN S Chief Scientific Officer Sale −300 $31.36 $9K 69,360
2021-11-18 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −300 284,800
2021-11-17 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,700 $6.55 $24K 73,060
2021-11-17 ROBINS HARLAN S Chief Scientific Officer Sale −3,700 $32.05 $119K 69,360
2021-11-17 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,700 285,100
2021-11-15 PISKEL KYLE Principal Accounting Officer Grant or award +3,837 6,699
2021-11-15 PISKEL KYLE Principal Accounting Officer Grant or award · Stock Option (Right to Buy) +9,592 9,592
2021-11-10 Cohen Chad M Chief Financial Officer Option exercise +5,000 $7.27 $36K 26,604
2021-11-10 Cohen Chad M Chief Financial Officer Sale −5,000 $33.93 $170K 21,604
2021-11-10 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 90,000
2021-11-09 Cohen Chad M Chief Financial Officer Option exercise +5,000 $7.27 $36K 26,604
2021-11-09 Cohen Chad M Chief Financial Officer Sale −5,000 $36.03 $180K 21,604
2021-11-09 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 95,000

Page 38 of 120 · 2,386 trades